ALS (Lou Gehrig’s Disease)

Stories of hope and scientific progress in the CIRM Annual Report

This past year, CIRM scientists made significant progress toward new therapies.

Stem cell progress on brain awareness week

This week marks Brain Awareness Week, with events worldwide to bring people up to speed on brain research. I went to the cool search tool on the Dana Foundation web site and found that several CIRM grantees are hosting events this week. That makes sense, given that roughly a quarter of our funding goes to neuronal diseases. (You can see charts of CIRM stem cell research funding allocations here. The charts are slightly out of date - stay tuned for some updates in the next month.)

A salute to caregivers from Leeza Gibbons

At CIRM we want nothing more than to find cures for the diseases that afflict people around the world. Until that day comes, many of the diseases we hope to cure - Alzheimer's disease, Parkinson's disease, spinal cord injury, ALS, to name a few - place an incredible burden on the caregivers in addition to the patients themselves.

Embryonic Stem Cells Generate Model for ALS

Researchers at the Salk Institute for Biological Sciences have grown embryonic stem cells into the motor neurons and support cells that underlie amyotrophic lateral sclerosis (ALS). Also known as Lou Gherig's Disease, ALS has no cure and no effective treatment. In this disease, the motor neurons slowly degenerate leaving a person paralyzed. Why the neurons die is not known, however the support cells called astrocytes have long appeared to play a role.

Subscribe to RSS - ALS (Lou Gehrig’s Disease)

© 2013 California Institute for Regenerative Medicine